drugset / Trial / NCT01093807

Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension

NCT01093807

Phase 2 Completed 1039 enrolled RECORDATI GROUP
RandomizedFactorialDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of various dosage combinations of lercanidipine (10 and 20 mg)and enalapril (10 and 20 mg) in comparison with their respective components and with placebo.

Timeline

Start
2010-03
Primary completion
2011-03
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Enalapril Other / unclassified 10 mg
Subject Enalapril Other / unclassified 20 mg
Subject Lercanidipine Small molecule 10 mg
Subject Lercanidipine Small molecule 20 mg